What is the debt of Fuso Pharmaceutical Industries this year?
Fuso Pharmaceutical Industries has a debt level of 7,602 JPY this year.
In 2024, Fuso Pharmaceutical Industries's total debt was 7,602 JPY, a 74.88% change from the 4,347 JPY total debt recorded in the previous year.
Fuso Pharmaceutical Industries's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing Fuso Pharmaceutical Industries's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to Fuso Pharmaceutical Industries’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in Fuso Pharmaceutical Industries’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Fuso Pharmaceutical Industries has a debt level of 7,602 JPY this year.
The debt of Fuso Pharmaceutical Industries has increased by 74.88% compared to the previous year increased.
High debt can pose a risk for investors of Fuso Pharmaceutical Industries, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that Fuso Pharmaceutical Industries has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of Fuso Pharmaceutical Industries can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of Fuso Pharmaceutical Industries can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of Fuso Pharmaceutical Industries include investments, acquisitions, operating costs, and revenue development.
The debts of Fuso Pharmaceutical Industries are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, Fuso Pharmaceutical Industries can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.
The current dividend yield of Fuso Pharmaceutical Industries is 3.42 %.
Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.
For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.42 %.
Fuso Pharmaceutical Industries is assigned to the 'Health' sector.
To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.
The dividends of Fuso Pharmaceutical Industries are distributed in JPY.
Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.